Ikena’s pipeline is supported by scientific research published by the Ikena R&D team, our collaborators, and by external experts.


Our pipeline is supported by scientific research performed by our in-house team and by external experts.

For links to relevant scientific publications and abstracts, please see below (subscriptions may be required to access full text of certain publications):

Sep 2018 | From Ikena Oncology

Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond

Apr 2018 | From External Experts

Oncogenic Signaling Pathways in The Cancer Genome Atlas

Mar 2018 | From External Experts

NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma

Dec 2017 | From External Experts

Targeting the IDO1/TDO2–KYN–AhR Pathway for Cancer Immunotherapy – Challenges and Opportunities

Developing breakthrough, patient-directed therapies for difficult to treat cancers.